Coya Therapeutics, Inc 10-K for FY2024
Coya Therapeutics, Inc. (COYA)
10-K
2025-03-18
For: 2024-12-31
View Original
Added on
April 11, 2026
About this 10-K
Coya Therapeutics, Inc filed this 10-K on March 18, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.55M
- down 40.8% from $6M a year earlier
- Net loss
- $14.88M
- compared with a net loss of $7.99M a year earlier
- Diluted EPS
- -$0.98
- compared with -$0.79 a year earlier